|
|
- 2019
Immunohistochemistry Biomarkers Predict Survival in Stage II/III Gastric Cancer Patients: From a Prospective Clinical TrialDOI: 10.4143/crt.2018.331 Keywords: Biomarkers, Stomach neoplasms, Prognosis, Thymidylate synthase, PD-L1, ERCC1 Abstract: Identification of biomarkers to predict recurrence risk is essential to improve adjuvant treatment strategies in stage II/III gastric cancer patients. This study evaluated biomarkers for predicting survival after surgical resection
|
